Intracranial responses with selective KRAS-G12C inhibitors in non-small cell lung cancer

被引：1
|
作者：
Lu, Kevin [1 ]
Husain, Hatim [1 ,2 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA USA
[2] Univ Calif San Diego, Div Med Oncol, 3855 Hlth Sci 3011, La Jolla, CA 92093 USA
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2023年 / 12卷 / 06期
关键词：
Non-small cell lung cancer (NSCLC); KRAS G12C; adagrasib; sotorasib; BRAIN METASTASES; NSCLC;
D O I：
10.21037/tlcr-23-26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1335 / 1337
页数：3
相关论文
共 50 条
  • [21] Novel KRAS Inhibitors for Treating Non-small Cell Lung Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (08): : 1201 - 1202
  • [22] Sotorasib in KRAS G12C-mutated non-small cell lung carcinoma
    Lorenz, Judith
    PNEUMOLOGIE, 2023, 77 (11): : 846 - 846
  • [23] Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
    Vaclova, Tereza
    Chakraborty, Atanu
    Sherwood, James
    Ross, Sarah
    Carroll, Danielle
    Barrett, J. Carl
    Downward, Julian
    de Bruin, Elza C.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
    Tereza Vaclova
    Atanu Chakraborty
    James Sherwood
    Sarah Ross
    Danielle Carroll
    J. Carl Barrett
    Julian Downward
    Elza C. de Bruin
    Scientific Reports, 12
  • [25] KRAS in non-small cell lung cancer
    Amanam, I.
    Gupta, R.
    Mambetsariev, I.
    Koczywas, M.
    Cristea, M.
    Massarelli, E.
    Reckamp, K. L.
    Salgia, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [26] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Lee, Arnold
    TARGETED ONCOLOGY, 2022, 17 (06) : 727 - 733
  • [27] Clinical Characteristics and Outcomes in Patients With KRAS G12C Mutated Non-Small Cell Lung Cancer
    Pellini, B.
    Ganesan, V.
    Wan, F.
    Sankararaman, S.
    Manyanont, S.
    Akhave, N.
    Baggstrom, M.
    Ward, J.
    Waqar, S.
    Morgensztern, D.
    Govindan, R.
    Devarakonda, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S209 - S210
  • [28] Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer
    Cui, Wanyuan
    Franchini, Fanny
    Alexander, Marliese
    Officer, Ann
    Wong, Hui-Li
    IJzerman, Maarten
    Desai, Jayesh
    Solomon, Benjamin J.
    LUNG CANCER, 2020, 146 : 310 - 317
  • [29] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2022, 17 : 727 - 733
  • [30] Data from CodeBreak 200 published in THE LANCET: Confirmed Superiority of Sotorasib over Docetaxel in Patients with non-small cell Lung Cancer with KRAS-G12C Mutation
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (06)
12345